Avrobio Inc logo

Avrobio Inc

NAS:AVRO (USA)  
$ 16.80 -0.02 (-1.41%) 11:09 PM EST
2.03
P/B:
0.71
Market Cap:
$ 62.85M
Enterprise V:
$ -27.41M
Volume:
-
Avg Vol (2M):
-
Trade In:
Volume:
-
Avg Vol (2M):
-

Business Description

Description
Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-03 for the treatment of Pompe disease.
Name Current Vs Industry Vs History
Cash-To-Debt 403.93
Equity-to-Asset 0.96
Debt-to-EBITDA 0.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 30.78
9-Day RSI 41.3
14-Day RSI 47.44
6-1 Month Momentum % 4.51
12-1 Month Momentum % 31.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 26.17
Quick Ratio 26.17
Cash Ratio 25.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4
Shareholder Yield % 23.81

Financials (Next Earnings Date:2025-02-08 Est.)

AVRO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AVRO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Avrobio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 8.28
Beta 0
Volatility % 73.83
14-Day RSI 47.44
14-Day ATR ($) 0.7228
20-Day SMA ($) 17.5008
12-1 Month Momentum % 31.13
52-Week Range ($) 10.5612 - 19.8
Shares Outstanding (Mil) 3.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Avrobio Inc Filings

Filing Date Document Date Form
No Filing Data

Avrobio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Avrobio Inc Frequently Asked Questions

What is Avrobio Inc(AVRO)'s stock price today?
The current price of AVRO is $16.80. The 52 week high of AVRO is $19.80 and 52 week low is $10.56.
When is next earnings date of Avrobio Inc(AVRO)?
The next earnings date of Avrobio Inc(AVRO) is 2025-02-08 Est..
Does Avrobio Inc(AVRO) pay dividends? If so, how much?
Avrobio Inc(AVRO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1